Assessing the Physiological Effects of Traditional Regional Diets Targeting the Prevention of Cardiovascular Disease: A Systematic Review of Randomized Controlled Trials Implementing Mediterranean, New Nordic, Japanese, Atlantic, Persian and Mexican Dietary Interventions by Klonizakis, Markos et al.
Assessing the Physiological Effects of Traditional Regional
Diets Targeting the Prevention of Cardiovascular Disease: 
A Systematic Review of Randomized Controlled Trials 
Implementing Mediterranean, New Nordic, Japanese, 
Atlantic, Persian and Mexican Dietary Interventions
KLONIZAKIS, Markos <http://orcid.org/0000-0002-8864-4403>, BUGG, Alex, 
HUNT, Beatrice, THEODORIDIS, Xenophon, BOGDANOS, Dimitrios P. and 
GRAMMATIKOPOULOU, Maria G.
Available from Sheffield Hallam University Research Archive (SHURA) at:
http://shura.shu.ac.uk/28986/
This document is the author deposited version.  You are advised to consult the 
publisher's version if you wish to cite from it.
Published version
KLONIZAKIS, Markos, BUGG, Alex, HUNT, Beatrice, THEODORIDIS, Xenophon, 
BOGDANOS, Dimitrios P. and GRAMMATIKOPOULOU, Maria G. (2021). Assessing 
the Physiological Effects of Traditional Regional Diets Targeting the Prevention of 
Cardiovascular Disease: A Systematic Review of Randomized Controlled Trials 
Implementing Mediterranean, New Nordic, Japanese, Atlantic, Persian and Mexican 
Dietary Interventions. Nutrients, 13 (9). 
Copyright and re-use policy
See http://shura.shu.ac.uk/information.html




Assessing the Physiological Effects of Traditional Regional
Diets Targeting the Prevention of Cardiovascular Disease:
A Systematic Review of Randomized Controlled Trials
Implementing Mediterranean, New Nordic, Japanese, Atlantic,
Persian and Mexican Dietary Interventions
Markos Klonizakis 1,2,* , Alex Bugg 1, Beatrice Hunt 1, Xenophon Theodoridis 3 , Dimitrios P. Bogdanos 4
and Maria G. Grammatikopoulou 4,5


Citation: Klonizakis, M.; Bugg, A.;
Hunt, B.; Theodoridis, X.; Bogdanos,
D.P.; Grammatikopoulou, M.G.
Assessing the Physiological Effects of
Traditional Regional Diets Targeting
the Prevention of Cardiovascular
Disease: A Systematic Review of
Randomized Controlled Trials
Implementing Mediterranean, New
Nordic, Japanese, Atlantic, Persian
and Mexican Dietary Interventions.
Nutrients 2021, 13, 3034. https://
doi.org/10.3390/nu13093034
Academic Editors: Yukio Yamori and
Rosa Casas
Received: 1 August 2021
Accepted: 27 August 2021
Published: 30 August 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Lifestyle, Exercise and Nutrition Improvement (LENI) Research Group, Sheffield Hallam University,
Sheffield S10 2BP, UK; a.bugg@shu.ac.uk (A.B.); beatriceehunt@gmail.com (B.H.)
2 Department of Nursing and Midwifery, College of Health, Wellbeing and Life Sciences, Sheffield Hallam
University, Sheffield S10 2BP, UK
3 Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, University Campus,
54124 Thessaloniki, Greece; xenophontheodoridis@gmail.com
4 Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences,
University of Thessaly, Biopolis, 41334 Larissa, Greece; bogdanos@med.uth.gr (D.P.B.); maria@ihu.gr (M.G.G.)
5 Department of Nutritional Sciences & Dietetics, Faculty of Health Sciences, Alexander Campus, International
Hellenic University, 57400 Thessaloniki, Greece
* Correspondence: m.klonizakis@shu.ac.uk; Tel.: +44-1-142-255-697
Abstract: Traditional regional diets are considered as sustainable dietary patterns, while many have
been examined with regard to their health benefits. The aim of the present systematic review was
to aggerate all evidence on the physiological effects of regional diets among adults at high risk
for cardiovascular disease (CVD). Three databases were searched for randomized controlled trials
(RCTs) implementing any regional diet (Mediterranean (MedD), Persian, Southern European Atlantic,
Japanese, Chinese, new Nordic, or other) while examining cardiovascular risk factors among adults at
increased risk. Primary outcomes included anthropometric indices and secondary outcomes involved
blood lipid concentrations, glucose metabolism, inflammation and other markers of CVD progression.
Twenty RCTs fulfilled the study’s criteria and were included in the qualitative synthesis, with the
majority implementing a MedD. Adherence to most of the regional diets induced a reduction in
the BW and anthropometric indices of the participants. The majority of RCTs with blood pressure
endpoints failed to note a significant reduction in the intervention compared to the comparator arm,
with the exception of some new Nordic and MedD ones. Despite the interventions, inflammation
markers remained unchanged except for CRP, which was reduced in the intervention groups of one
new Nordic, the older Japanese, and the Atlantic diet RCTs. With regard to blood lipids, regional diet
interventions either failed to induce significant differences or improved selective blood lipid markers
of the participants adhering to the experimental regional diet arms. Finally, in the majority of RCTs
glucose metabolism failed to improve. The body of evidence examining the effect of regional dietary
patterns on CVD risk among high-risk populations, while employing an RCT design, appears to be
limited, with the exception of the MedD. More research is required to advocate for the efficacy of
most regional diets with regard to CVD.
Keywords: NCD; obesity; hypertension; medical nutrition therapy; nutrition transition; territorial
diet; noncommunicable disease; cardiovascular health; inflammation; sustainable diet
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1. Introduction
Noncommunicable diseases (NCDs), including ischemic heart disease, stroke, cancer,
diabetes and chronic lung disease, are collectively responsible for almost 71% of global
deaths—over 41 million in total [1]. Among these, 15 million are considered as “premature”
deaths, occurring between the ages of 30 and 69 years old [1] and could potentially be
avoided. NCDs come also with a large financial burden to both the society, the individual
household level and the national healthcare systems [2,3] as well as a substantial disability
burden [4].
NCDs are the confluence of genetics, physiological, behavioral and environmental
triggers [5]. As per the World Health Organization (WHO), the NCDs include five main
categories namely cardiovascular diseases (CVDs), cancers, chronic respiratory diseases,
diabetes [5] (Figure 1), and the more recent inclusion of mental health and wellbeing [6].
These five categories often co-occur, sharing intertwined causes. Proximal causes for the
development of NCDs include elevated total cholesterol (TC), blood pressure (BP), and
fasting plasma glucose (FPG) levels, whereas intermediate causes involve tobacco smoking,
unhealthy diets, physical inactivity and excessive alcohol consumption [7].
Figure 1. Non-communicable diseases categories.
Among all NCDs, CVDs consist of the leading cause of disease burden globally,
demonstrating an alarmingly high rate [8]. Moreover, over the past few years, the global
epidemiological CVD landscape has changed dramatically, with unhealthy diet becoming
an increasingly important modifiable factor for the development of CVD causes [9].
Nutrition-based lifestyle interventions have been recommended as a primary and
secondary prevention strategy for NCDs and for CVD in particular, for all high-risk pop-
ulations (e.g., those who are obese, physically inactive, smoking, consuming unhealthy
diets or excessive amounts of alcohol, etc., [10–12]). According to the WHO, globalization
has produced a global deviation in dietary patterns, known as nutrition transition [13–15],
which is responsible for the recorded cumulative increase in NCD burden, regarding the
CVD domain in particular [11]. For this, the effect of traditional regional diets (i.e., tradi-
tional dietary patterns from different regions of the world) have been extensively examined
for the prevention of NCDs. For example, Mediterranean diet (MedD) interventions have
been suggested to reduce CVD risk among older adults or post-menopausal populations,
both as standalone dietary interventions [16,17] or in conjunction with exercise [18,19], of-
fering both short- [17–19] and long-term benefits [20]. Similar findings have been reported
in studies assessing the new Nordic [21,22], the Japanese [23], the Southern European
Atlantic [24], and the Mexican [25] regional diets.
The aim of the present systematic review was to aggerate all available evidence on the
physiologic effects of regional diets among adults at high risk for developing CVD.
2. Materials and Methods
2.1. Research Question, PICO and Study Protocol
The research question was “what is the effect of regional diets in ameliorating anthro-
pometric, biochemical, and cardiovascular indices in adults at high risk for developing
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CVD?” Randomised controlled trials (RCTs) were screened according to the population,
intervention, comparison, and outcome (PICO) criteria (Table 1).
The protocol was registered at PROSPERO (CRD42020201200), and the review is
presented in accordance with the Preferred Reporting Items for Systematic Reviews and
Meta-Analysis (PRISMA) guidelines.




Adults at high risk for CVD (age ≥ 55 years old and at least one of the following risk factors
1. post-menopausal, 2. with hyperglycemia or prediabetes, 3. hypertension, 4. hyperlipidemia,
5. overweight/obesity, 6. current cigarette smokers, or 7. excessive alcohol drinkers,
8. physically inactive)
Intervention: Any regional diet, including the Mediterranean, Persian, Southern European Atlantic,Japanese, Chinese, Nordic, or other.
Comparison: Habitual diet, sham diet, any other dietary pattern, or no intervention
Outcome: Any CVD outcome, including BW, BMI, WC, body fat (% BW), waist-to-hip ratio, blood pressure, insulinresistance, fasting blood glucose/insulin, HbA1c, blood lipids, FMD or LDF
BMI, body mass index; BW, body weight; CVD, cardiovascular diseases; FMD, Flow Mediated Dilatation; HbA1c, glycosylated haemoglobin;
LDF, laser Doppler Fluximetry; WC, waist circumference.
2.2. Search Strategy
The PubMed, Excerpta Medica Database (Embase) and Cochrane Central Register of
Controlled Trials (CENTRAL) databases were searched from inception until August 2020.
In parallel, the search was also extended to the gray literature. Used search terms, with a
combination of MeSH terms whenever applicable in each database, included: (Japanese
diet), (Mediterranean diet), (Nordic diet), (Atlantic diet), (Mexican diet), (Persian diet),
(Chinese diet), (obesity), (adiposity), (adipose tissue), (body fat), (overweight), (obese),
(body mass index), (blood pressure), (hypertension), (hypertensive), (insulin), (insulin sen-
sitivity), (diabetes), (diabetic), (hyperlipidaemia), (cholesterol), (triglyceride), or (weight).
A detailed search string for the PubMed database is presented in Table 2.
Table 2. Detailed search strings used for the PubMed database.
1
“Mediterranean diet”[Abstract] AND (“fatness”[Abstract] OR “body fat”[Abstract] OR “adiposity”[Abstract] OR
“obesity”[Abstract] OR “obese”[Abstract] OR “BMI”[Abstract] OR “blood pressure”[Abstract] OR “glucose”[Abstract]
OR “insulin”[Abstract] OR “cholesterol”[Abstract] OR “flow mediated dilation”[Abstract] OR “laser doppler”[Abstract]
OR “weight”[Abstract] OR “circulation”[Abstract])
2
mexican diet[Abstract] AND (fatness[Abstract] OR body fat[Abstract] OR adiposity[Abstract] OR obesity[Abstract] OR
obese[Abstract] OR BMI[Abstract] OR blood pressure[Abstract] OR glucose[Abstract] OR insulin[Abstract] OR
cholesterol[Abstract] OR flow mediated dilation[Abstract] OR laser doppler[Abstract] OR weight[Abstract]
OR circulation[Abstract])
3
persian diet[Abstract] AND (fatness[Abstract] OR body fat[Abstract] OR adiposity[Abstract] OR obesity[Abstract] OR
obese[Abstract] OR BMI[Abstract] OR blood pressure[Abstract] OR glucose[Abstract] OR insulin[Abstract] OR
cholesterol[Abstract] OR flow mediated dilation[Abstract] OR laser doppler[Abstract] OR weight[Abstract]
OR circulation[Abstract])
4
chinese diet[Abstract] AND (fatness[Abstract] OR body fat[Abstract] OR adiposity[Abstract] OR obesity[Abstract] OR
obese[Abstract] OR BMI[Abstract] OR blood pressure[Abstract] OR glucose[Abstract] OR insulin[Abstract] OR
cholesterol[Abstract] OR flow mediated dilation[Abstract] OR laser doppler[Abstract] OR weight[Abstract]
OR circulation[Abstract])
5
(“New Nordic diet”[Abstract] OR “Nordic diet”[Abstract]) AND (fatness[Abstract] OR “body fat”[Abstract] OR
“adiposity”[Abstract] OR “obesity”[Abstract] OR “obese”[Abstract] OR “BMI”[Abstract] OR “blood pressure”[Abstract]
OR “glucose”[Abstract] OR “insulin”[Abstract] OR “cholesterol”[Abstract] OR “flow mediated dilation”[Abstract] OR
“laser doppler”[Abstract] OR “weight”[Abstract] OR “circulation”[Abstract])
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Table 2. Cont.
6
“Japanese diet”[Abstract] AND (“fatness”[Abstract] OR “body fat”[Abstract] OR “adiposity”[Abstract] OR
“obesity”[Abstract] OR “obese”[Abstract] OR “BMI”[Abstract] OR “blood pressure”[Abstract] OR “glucose”[Abstract]
OR “insulin”[Abstract] OR “cholesterol”[Abstract] OR “flow mediated dilation”[Abstract] OR “laser doppler”[Abstract]
OR “weight”[Abstract] OR “circulation”[Abstract])
7
“Atlantic diet”[Abstract] AND (“fatness”[Abstract] OR “body fat”[Abstract] OR “adiposity”[Abstract] OR
“obesity”[Abstract] OR “obese”[Abstract] OR “BMI”[Abstract] OR “blood pressure”[Abstract] OR “glucose”[Abstract]
OR “insulin”[Abstract] OR “cholesterol”[Abstract] OR “flow mediated dilation”[Abstract] OR “laser doppler”[Abstract]
OR “weight”[Abstract] OR “circulation”[Abstract])
2.3. Inclusion and Exclusion Criteria
Inclusion criteria for the synthesis involved (1) publications written in the English
language, (2) with a RCT design (parallel or cross-over), (3) with participants having a good
general health but who were high risk for the development of CVD according to the WHO
(age ≥55 years old, and at least one risk factor including post-menopause, hyperglycemia
or prediabetes, hypertension, hyperlipidaemia, overweight or obesity, cigarette smokers,
excessive alcohol drinkers, or physically inactive), (4) with one intervention implementing
a traditional regional diet only, (5) a comparator arm implementing any other diet, sham
diet, or no intervention, and (6) the duration of intervention lasting for at least 4 weeks.
Exclusion criteria involved (1) publications written in languages other than the En-
glish, (2) lacking an RCT design, (3) with participants having a confirmed diagnosis of
chronic obstructive pulmonary disease, Parkinson’s Disease, any form of cancer, or dia-
betes mellitus diagnosis, (4) incomplete trials, (5) lacking an intervention implementing a
traditional territorial diet, (6) implementing a parallel exercise intervention, (7) involving
younger participants.
2.4. Outcomes of Interest
Primary outcomes included body weight (BW), body mass index (BMI), waist circum-
ference (WC), waist-to-hip ratio and abdominal adiposity.
Secondary outcomes included body fat (as a % of BW), systolic blood pressure (SBP),
diastolic blood pressure (DBP), FPG, fasting insulin (Ins), insulin resistance (IR), glycosy-
lated haemoglobin (HbA1c), TC, low-density lipoprotein (LDL), high-density lipoprotein
(HDL), TC:HDL ratio, and Flow Mediated Dilatation (FMD), as well as inflammation and
atheromatosis markers.
2.5. Data Extraction
An a priori data extraction form was created in Microsoft Excel (version 16.0). Two
researchers (A.B. and B.H.) independently extracted all of the data using the form, with two
senior researchers (M.K. and M.G.G.) independently checking all of the data for consistency.
Extracted data included bibliographic information, study, and participant charac-
teristics, randomization, wash-out periods (in case of cross-over studies), intervention
characteristics, treatment duration, and comparator and outcome data including any rele-
vant parameters named in the primary and secondary outcomes. In the case of any missing
or unclear data, two attempts were made to contact the corresponding author by email. If
no response was received, the missing data were not included.
2.6. Risk of Bias in Individual Studies
The Cochrane Risk of Bias (RoB) 2.0 tool [26] was used to assess the quality at the
study level as having a high, low, or unclear risk of bias. The tool evaluates studies based
on seven criteria: (1) randomization generation, (2) allocation concealment, (3) blinding of
outcome assessors, (4) blinding patients/study personnel, (5) incomplete outcome data
(that is, lost to follow-up), (6) selective outcome reporting, and (7) other risks of bias.
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3. Results
3.1. Search Results
The initial search of databases identified a combined total of 8173 records. After
screening the titles, a total of 20 distinct RCTs fulfilled the predefined criteria and were
subsequently included in the qualitative synthesis. A detailed PRISMA flow chart of the
RCT selection process is presented in Figure 2.
Figure 2. PRISMA flowchart of the study selection process.
3.2. Characteristics of the Included RCTs
3.2.1. Intervention and Comparator Arms
Table 3 describes the characteristics of the included RCTs. One RCT assessed the
effect of the traditional Japanese diet [27,28], another implemented a traditional Chinese
diet intervention [29], three RCTs evaluated a new Nordic diet intervention [30–32], two
RCTs assessed the effect of the Traditional Persian Medicine (TPM) diet [33,34], one trial
evaluated adherence to the Mexican diet (MexD) [35], one the Southern European Atlantic
Diet (SEAD) [24] and a total of 12 RCTs assessed the results of MedD interventions [36–49].
Traditional territorial diets were compared against average modern diets of the
same region [27,28,30,32,36,37], the typical western/US diet [29,31,35,47], the habitual
diet of inhabitants of that area [24,38–41,48,49], known healthy diets such as the low-fat
diet [33,39,42,43]; the dietary approaches to stop hypertension (DASH) diet [45]; hypocaloric
diets with oral nutrient supplements (ONS) [34]; diets supplemented with fish oil, walnuts,
and grape juice [38]; weight-loss medication [33,34]; the Atkins diet [46]; or a lacto-ovo
vegetarian diet [44].
3.2.2. RCT Design, Masking and Duration
Most RCTs were of parallel design, with a small number (n = 4) implementing cross-over
interventions [35,42–44]. There were three trials that had double-blind masking [32,45], four
were single-blind [34–37,39], the majority were open label [24,30,33,38,40,42,44,46–50], and
one did not report blinding at all [29]. Intervention duration ranged between 28 days [27,28]
and a total of 26 weeks [30].
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TC, LDL
8-iso-PGF2a, 8-iso-prostaglandin F2a; ADMA, asymmetrical dimethylarginine; ALB, albumin; ALT, alanine transaminase; ALP, alkaline
phosphatase; apoA1, apolipoprotein A1; apoB, apolipoprotein B; AST, aspartate aminotransferase; BF, body fat; BMI, body mass index;
BUN, blood urea nitrogen; BW, body weight; Ca, Calcium; CK, creatine kinase; CARDIVEG, Cardiovascular Prevention With Vegetarian
Diet; Cl, cloride; Cre, creatinine; CRP, c-reactive protein; CVD, cardiovascular disease; DASH, dietary approach to stop hypertension; DBP,
diastolic blood pressure; F2-IsoPs, F2-isoprostanes; FA, fatty acids; Fe, Iron; FFM, fat-free mass, FMD, flow-mediated dilation; FPG, fasting
plasma glucose; GALIAT, Galicia Alimentación Atlántica; Hb, hemoglobin; HbA1c, glycosylated haemoglobin; HC, hips circumference;
HDL, high density lipoprotein; HOMA-IR, insulin resistance homeostatic model of assessment; hs-CRP, high sensitive C-reactive protein;
HWR, hip-to-waist ratio; IDF, International Diabetes Federation; IER, intermittent energy restriction; IGF-1, insulin growth factor 1; IGT,
impaired glucose tolerance; IGFBP-3, insulin-like growth factor binding protein 3; IL-6, interleukin 6; INFγ, interferon γ; Ins, insulin;
IRI, immune-reactive insulin; K, potassium; LD, lactate dehydrogenase; LDL, low density lipoprotein; LpA, lipoprotein A; MCH, mean
corpuscular Hb; MCV, mean corpuscular volume; MedD, Mediterranean diet; MexD, Mexican diet; MDB, Majoon Davaye Balgham;
MedLey, Mediterranean diet for cognitive and cardiovascular health in the elderly; MetS, Metabolic Syndrome; Mg, magnesium; MHI,
mental health index; Na, sodium; NAFLD, non-alcoholic fatty-liver disease; NCEP-ATP III, National Cholesterol Education Program—Adult
Treatment Panel III; NR, not reported; OHA, oral hypoglycemic agents; ONS, oral nutrient supplements; PHI, physical health index; PTL,
platelets; RBC, red blood cells; RDN, registered dietitian-nutritionist; SBP, systolic blood pressure; SEAD, Southern European Atlantic diet;
serv, serving; sTNFR1, soluble tumor necrosis factor receptor 1; T2DM, type 2 diabetes mellitus; TC, total cholesterol; TG, triglycerides;
TMAO, trimethylamine N-oxide; TNF-a, tumor-necrosis factor a; TP, total protein; TPM, Traditional Persian Medicine; UA, uric acid; BUN,
blood urea nitrogen; US, ultrasound; VAT, visceral adipose tissue; VLDL, very low density lipoprotein; WBC, white blood cells; WC, waist
circumference; † mean standard deviation.
3.2.3. RCT Population
The pooled number of participants reached a total of 3486 participants. Most stud-
ies used patients with overweight simple or abdominal obesity [27,29,30,34,35,38,45–47],
patients with hypercho-lesterolaemia [31,32,42,43] or at least one cardiometabolic risk
factor [42–44], elevated hs-CRP [32], NAFLD [33], or older adults [40,48,49].
3.2.4. Outcomes of the Included Trials
Outcomes of cardiovascular (CV) interest in the included RCTs involved anthropo-
metric indices (BW, BMI, waist circumference, hips circumference, BF, FFM, VAT, hips-to-
waist ratio), indicators of glucose and insulin metabolism (FPG, Ins, HOMA-IR, Matsuda
Index, HbA1c), changes in the NAFLD grade, blood pressure (SAP and DAP), FMD, in-
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flammation markers (TNF1, IL-6, CRP, etc.), indirect carotid intima-media thickness via
asymmetric dimethylarginine (ADMA) assay, blood lipid concentrations (HDL, LDL, TC,
TG, apolipoproteins, etc.) and cytokines levels.
Moreover, few trials also included non-CV-specific outcomes, like stress, cognitive
function, well-being, depression [39], 8-iso-prostaglandin F2a (8-iso-PGF2a), a marker
of oxidative stress [46], sagittal diameter, physical fitness [30], blood mineral concentra-
tions [27,28], hunger, as well as subjective physical and mental health [29].
3.3. Characteristics of the Traditional Regional Diets
Characteristics of the traditional regional diets included in the RCTs are presented
in Figure 3. The traditional Japanese diet is based on several elements, including a high
consumption of soy products, fish and shellfish, vegetables (pickles in particular), seaweed,
mushrooms, fruit, and green tea [27,51]. Specific condiments of the dietary pattern include
dashi (soup stock) and fermented seasoning (soy sauce, miso, vinegar, mirin, and sake),
with rice and soup being consumed as part of the meals.
Figure 3. Characteristics of the regional diets included in the systematic review.
The traditional Chinese diet is similar to the Japanese one, including pickled vegeta-
bles, dry- and brine-slated vegetables, jellyfish, fish-balls and salted fish, soups, poultry,
tofu and tofu by-products (koji), rice and rice snacks, fermented sauces, and eggs (salted
and thousand-year-old) [52].
The new Nordic diet [53] is rich in high-fiber plant foods (fruits, berries, vegetables,
whole grains, nuts), rapeseed oil, fish, and low-fat milk products. Salt intake, sugar, and
saturated fats are rarely consumed.
Characteristics of the MedD include a high intake of vegetables, legumes and fruit,
grains and nuts, olive oil as the main cooking fat, plenty of fish and shellfish as well as
regionally grown herbs [54–56].
The traditional Persian diet includes a great variety of rice-based dishes (rice with
stew, cooked rice, mixed pilaf, rice in a high-protein dish, vegetables stuffed with rice
and kofta, or tahchin), soups and pottages, and many desserts, some which are rice- or
semolina-based (halva, digcheh, milk-rice pudding, rice cookies, rice flour pudding, or
saffron rice pudding) [57].
As for the traditional Mexican diet, it is rich in grains and tubers, maize products (corn
tortillas), legumes, vegetables, fruits, meats, herbs and condiments [25]. Typical dishes
include a variety of corn-based dishes that are mainly cooked with chilies, onions, garlic,
and herbs (e.g., tamales), beans, squash, meats, rice, citrus fruits, full-fat milk, vegetables,
Mexican cheeses, and lard [35]. Moreover, the diet is low in refined grains and added
sugars [58].
Finally, the Atlantic diet is based on a frequent consumption of bread, cereals (in-
cluding whole-grain), rice, pasta, potatoes, fruit, vegetables (including vegetable soup)
and olive oil, a daily intake of dairy products, frequent consumption of nuts (preferably
chestnuts or walnuts), fish (in particular cod) and seafood [59,60]. Eggs, lean meat, and
pulses are also consumed on a weekly basis (2–3 times), whereas fatty meats and cured
sausages, butter and margarine as well as desserts, sweets, pastries, cakes, and ice cream
are sparingly consumed [60].
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3.4. Effects of Regional Diets on CVD Prevention among Participants with Increased CVD Risk
Table 4 details the CVD outcomes of the individual RCTs favoring the regional diet
intervention arms.
Table 4. Overview of CVD-specific outcomes (favoring the intervention arm) in RCTs implementing regional dietary




























































































































































































Japanese Asano [27,28] ↓ ↓ ↓ ↓ - ↓ ↓ ↑ ↓ - - - ↓ - -
Chinese Leonetti [29] ↓ ↓
Nordic Adamsson [31] - ↓ ↓ ↓ - ↓ ↓ ↓ ↓ - ↓ - ↓
Poulsen [30] ↓ ↓ ↓ ↓ ↓ - - - ↓ ↓ ↓ - - -
Ulven [32] ↓ - - - - ↓ ↓ ↓ ↓ - ↓ - - - - -
MedD
Bos [47] - - - - - - - -
Buscemi [46] ↓ - - - - ↑
Davis [48,49] - - - ↓ ↓ ↓ ↑ - -
Duś-Żuchowska [36,37] ↓ ↓ ↓ - ↓ - ↓
Jaacks [38] ↓ - ↓ - ↓ - - -
Jennings [40] ↓ -
Sofi [44] - - - - - ↓ ↓ - -
Panizza [45] ↓ ↓ ↓ ↓ ↓ - - - - - -
Wade [42] ↓ ↓ - ↓ - - - - - - - - -
Wade [43] ↓ - ↓ - - ↓ - ↓ ↓ - - -
Wardle [39] ↓ ↓ - ↓ -
Mexican Santiago-Torres [35] - - ↓ - -
Persian Ghayour Razmgah [33] ↓
Hamidnia [34] - - - - - - - - -
Atlantic Calvo-Malvar [24] ↓ ↓ ↓ ↓ - - ↓ - ↓ - - - - -
ADMA, asymmetric dimethylarginine; apoA1, apolipoprotein A1; ApoB, apolipoprotein B; BMI, body mass index; BF, body fat; BW,
body weight; CRP, c-reactive protein; DBP, diastolic blood pressure; FFM, fat-free mass; FMD, brachial artery flow-mediated dilation;
FPG, fasting blood glucose; HbA1c, glycosylated haemoglobin; HDL, high density lipoprotein; HOMA-IR, insulin resistance homeostatic
model of assessment; hs-CRP, high-sensitivity CRP; HWR, hips-to-waist ratio; IL-6, interleukine 6; IFNγ, interferon-γ; Ins, insulin; IR,
insulin resistance; LBM, lean body mass; LDL, low density lipoprotein; MedD, Mediterranean diet; SBP, systolic blood pressure; TC, total
cholesterol; TG, triglycerides; TNF-α, tumor-necrosis factor α; sTNFR1, soluble TNF receptor 1; VAT, visceral adipose tissue; WC, waist
circumference; * Based on the HOMA-IR or the Matsuda Index; ↓ reduced; ↑ elevated.
Adherence to most of the regional diets induced a reduction in the BW and anthropo-
metric measures of participants.
The majority of trials with BP endpoints failed to note a significant reduction in the in-
tervention compared to the comparator arm, with the exception of some new Nordic [30,31]
and MedD [40,43,48,49] interventions.
Despite the interventions, inflammation markers remained unchanged, except for
CRP, which was reduced in the intervention groups of one new Nordic [25], the older
Japanese [27,28], and the Atlantic diet [24] RCTs.
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With regard to blood lipid concentrations, the regional diet interventions either failed
to induce significant differences or improved the lipid profile of participants adhering to
the experimental regional diets.
Finally, in the majority of the RCTs, glucose metabolism failed to improve in partici-
pants with increased CV risk.
3.4.1. Japanese Diet and CVD Prevention
One trial [27,28] assessed the effect of the older Japanese diet compared against the
modern Japanese diet among patients with overweight/obesity. Anthropometric indices
(BW, BMI and body fat mass) were improved in the arm adhering to the older Japanese diet,
whereas in parallel, HDL, LDL, CRP and HbA1c were also improved. No changes were
noted with regard to the FPG, IR evaluated through the homeostatic model assessment for
IR (HOMA-IR), alanine transaminase (ALT), or blood pressure.
3.4.2. Chinese Diet and CVD Prevention
Leonetti and associates [29] compared the Chinese diet against the typical Western one,
both in a hypo-caloric version, among patients with overweight/obesity. After six weeks of
intervention, BMI, lean body mass (LBM), subjective hunger, as well as reported physical
and mental health indicators were improved in the arm adhering to the Chinese diet.
3.4.3. New Nordic Diet and CVD Prevention
Among the three RCTs evaluating a new Nordic diet intervention (NorD) [30–32],
one used the typical Western diet as a comparator [31], and the remaining assessed dif-
ferences between the new Nordic diet (a healthier version of the diet) compared to the
typical/average contemporary Danish diet [30,32].
Adherence to the new Nordic diet for 6 weeks [31] among patients with hypercholes-
terolaemia induced a significant reduction in the BW and BMI of the participants in the
intervention arm compared to those allocated to the Western diet group. SBP, fasting
insulin, TC, LDL, HDL, LDL/HDL ratio, apolipoprotein A1 (ApoA1) and B (ApoB) con-
centrations as well as their ratio (apoB/apoA1) were also improved. No differences were
recorded with regard to the FPG and DBP levels.
When the new Nordic diet was compared against the typical Danish diet among
patients with abdominal obesity [30], all of the anthropometric indices were improved
in parallel to the SBP, IR, TG, TC, and CRP levels. However, no differences were noted
in the FPG and insulin levels between treatment arms. Adhering to a high-fiber Nordic
diet for eight weeks [32] improved BW and blood lipid levels (TC TG, LDL and HDL)
among participants with elevated TC and high-sensitivity CRP (hs-CRP) at baseline. The
intervention failed to induce improvements with regard to blood pressure, FPG, insulin,
HbA1c, hs-CRP, interleukin-6 (IL-6), ALT, interferon γ (IFNγ), soluble tumor necrosis factor
receptor 1 (sTNFR1), apoB, or apoA1 levels.
3.4.4. Mediterranean Diet and CVD Prevention
Compared to a Western-style diet, the MedD was ineffective in improving the an-
thropometric, lipid, and FPG profile of non-diabetic patients with abdominal obesity [47]
after 10 weeks of intervention. On the other hand, when participants with overweight or
simple obesity were recruited [38], BW, TC, and LDL were significantly improved within
8 weeks in the treatment arm compared to the group retaining their usual diet alone or
supplemented with fish oil, walnuts, and grape juice.
When the comparative effectiveness of an isocaloric MedD was compared against
the DASH diet for 12 weeks [45] in a similar sample, all of the athropometric indices
(BW, WC, BF, and visceral adipose tissue [VAT]) and additionally ALT were improved
in the MedD arm. In a 2-month comparative effectiveness trial where one group of
women with overweight/obesity adhered to a hypo-caloric MedD and another to the
Atkins diet [46], BW and FMD were significantly improved in the MedD arm. When the
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MedD was compared against an energy-restricted Central European dietary pattern for
6 weeks, BW, BF, FFM, and VAT were all reduced among post-menopausal women with
overweight/obesity [36,37]. Nevertheless, no differences were recorded in the ADMA or
hs-CRP concentrations of participants.
The Cardiovascular Prevention with Vegetarian Diet (CARDIVEG) [44] trial assessed
the effect of a hypo-caloric MedD compared against a low-calorie lacto-ovo vegetarian diet
for 3 months, in patients at increased CVD risk. Among a variety of hematological and
anthropometric outcomes, only LDL and TG levels were improved.
When older adults were used as a sample, a yearly MedD intervention was effective
in improving SBP [40,48,49]. Moreover, the Mediterranean diet for cognitive and cardio-
vascular health in the elderly (MedLey) trial [48,49] revealed additional improvements
regarding the DBP, FMD, TG, and F2-isoprostanes levels at 6 months of intervention.
In the MedDairy [43] and MedPork [42] trials, Wade and associates compared the
MedD supplemented with servings dairy or lean pork, respectively, against a low-fat
diet for 8 weeks among patients at risk for CVD. In MedDairy [43], reductions in the
anthropometric indices were noted (BW and BF), paired with improved SBP, HDL, and TG
levels. In MedPork [42], the BW, BMI, and WC of the participants were improved. None of
trials managed to improve LDL, DBP, FPG, fasting insulin, or TC levels.
When patients with mildly/moderately elevated TC levels were recruited, adherence
to the MedD induced significant improvements in the BW, TC, and LDL levels compared
to either a low-fat diet or the usual diet of the participants [39]. Nonetheless, measures
of stress, cognitive function, well-being, and depression failed to change despite the
intervention.
3.4.5. Mexican Diet and CVD Prevention
Santiago-Torres and colleagues [35] evaluated a traditional Mexican diet intervention
compared against the US diet in women with overweight/obesity for a total of 24 days in a
cross-sectional manner. Among the plethora of evaluated outcomes only fasting insulin
levels were improved post-intervention, with FPG, CRP, insulin-growth factor 1 (IGF-1),
insulin-like growth factor binding protein 3 (IGFBP-3), adiponectin, IL-6, and IR failing to
be improved.
3.4.6. Traditional Persian Medicine Diet and CVD Prevention
Two RCTs compared the TPM against hypo-caloric diets [33,34] in patients with
NAFLD [33] and women who were overweight [34], respectively. In the first RCY [33],
BMI, NAFLD grade, ALT, and aspartate aminotransferase (AST) levels were significantly
improved in the TPM arm, as compared to the low-fat hypo-caloric diet group. In the
second trial, no improvements were noted, either when compared against the typical
hypo-caloric diet (1200–1600 kcal/day) plus orlistat, or when compared to the typical
hypo-caloric diet plus Majoon Davaye Balgham (MDB) ONS.
3.4.7. Traditional Southern European Atlantic Diet and CVD Prevention
The GALIAT study [24] assessed the results of a traditional Atlantic diet interven-
tion in in 250 families (irrespective of their health status), compared to their habitual
diet. The intervention induced a reduction in anthropometric indices (BW, BMI, BF), as
well as in the TC and LDL concentrations. No differences were reported with regard to
inflammation markers.
3.5. Risk of Bias
A summary risk of the bias of the included RCTs is presented in Figure 4. The majority
of RCTs had an unclear overall risk of bias, three had a low overall bias, and five were
classified as having a high overall risk of bias.
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Figure 4. Randomized controlled trials, investigating the effects of MD interventions, rated by the
Cochrane risk of bias tool [26].
3.6. Synthesis of the Outcomes
Although the number of studies and the total patient population were adequate, the
high clinical and methodological heterogeneity did not allow for a synthesis of the outcomes.
4. Discussion
The present study revealed that research applying regional dietary interventions while
examining CVD outcomes is very limited. From the examined dietary patterns, the MedD
appears to be the most researched diet using an RCT design. Although individual RCTs
indicate selective improvements in CVD outcomes following adherence to regional dietary
interventions, any extrapolation of the findings for the formulation of recommendations
would be rather premature and hasty.
4.1. Do Health Benefits Lie in the Constituents/Nutrients of Regional Diets?
According to Cena and Calder [61], healthy dietary patterns are apparent in certain
regions of the world and are rooted in the local tradition while making use of the naturally
available food sources in a sustainable manner [62]. Thus, to evaluate the potential benefi-
cial effects of regional diets on CVD risk factors, it seems appropriate to consider the food
sources, and quantities thereof, provided in the pre-scribed dietary interventions that might
consist of the driving forces behind the improved health outcomes. Common denominators
in the healthier, regional dietary interventions include a high fruit and vegetable intake,
the consumption of fish and plant oils as well as the low intake of fat, sugar, sweets, and
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desserts (Figure 5). For each one of these diet components, a great body of evidence is
backing the health benefits associated with its consumption.
Figure 5. Shared food-group components of regional diets included in the present analysis.
Collectively, the dietary interventions implemented herein suggest an increased con-
sumption of fruits and vegetables. This pattern has been shown to reduce serum TC in
healthy men and women [6] and has been inversely related to LDL concentrations in healthy
individuals and individuals with T2DM or coronary artery disease (CAD) [63]. Fruits and
vegetables have a high fiber content, which, in turn, may reduce the glycemic index of
foods, conferring benefits against CVD or its precursors (glycemic control, BW, etc.) [64].
Moreover, a high fruit and vegetables intake usually coincides with a reduced intake
of sweets and sugar, indicating the adoption of a “healthier” dietary pattern. Literature is
unanimous on the beneficial effects of low sugar intake on CV health [65,66], with benefits
spanning from low subclinical inflammation [67], improved gut microbiota [68], and the
attainment of a “healthy” body weight [69].
With regard to the fat intake, several studies have associated a higher fats intake,
particularly SFA, to greater LDL concentrations, and the development of inflammation,
T2DM and dyslipidemia [70]. Indeed, for many years, even the smallest intake of fat was
“demonized” and a high-fat diet was a synonym to a higher CVD-risk diet [71]. Recently
however, evidence from studies of higher hierarchy, including dose-response meta-analyses,
has contradicted this narrative, suggesting that SFA intake has either a null effect, or even
a positive one on the CV health according to the results of dose-response analyses [71–73].
Moreover, according to a recent Cochrane systematic review [74], cutting down on SFA for a
period of four years has little or no effect on non-fatal myocardial infarction, coronary heart
disease (CHD) and cancer mortality/incidence, diabetes diagnosis, HDL and serum TG
concentrations, or blood pressure, and unclear effects on total myocardial infarction (MI),
stroke and CHD events. Moreover, the number-needed-to-treat (NNT) for an additional
beneficial outcome based on the primary prevention trials was 56, translating to 56 people
needed to reduce their SFA intake for four years, in order for one person to avoid a CVD
event [74]. When secondary prevention trials were accounted for, the NNT was calculated
at 32 [74]. Accordingly, some researchers claim that the absolute intake of macronutrients
appears to be less relevant to health than the selected food sources [75].
A high fish intake is an indisputable component of most of the regional diets in-
cluded herein, and interestingly, all regional diets included in the present analysis involved
countries with direct access to the sea. Research has showed that fishing is an important
contributor to food security in water surrounding regions [76], and seafoods form both a
traditional component of the regional diets, as well as an important effector of diet qual-
ity [77]. Moreover, according to meta-analyses of observational studies, greater fish intake
is associated with a lower CHD incidence and mortality [78], as well as stroke risk [79].
Despite the health effects demonstrated by the consumption of individual foods and
food-groups, as Schoenfeld and Ioannides promptly noted, it is risky to associate individual
foods and nutrients with distinct health outcomes, as nutritional epidemiology is often
biased by its limited reproducibility [54,80].
4.2. Concerns Regarding the Methodology of the Included RCTs
In the Japanese diet trials, the intervention arm (traditional diet) contained an in-
creased quantity of soy products, seafood, fruits and vegetables, seaweed, and mushrooms
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compared to the comparator [27]. The 1975 Japanese diet servings contained approximately
4 g less fat per 100 g, 1 g more protein and 1 g extra carbohydrate compared to the modern
diet. Differences in the macronutrient content of the two arms appear neglectable or non-
different between arms; thus, it is the actual foods and their constituents that may have
propelled the changes in the metabolic profile of participants, although this is difficult to
discern when only one RCT was included.
In the Chinese diet RCT, the reported dietary information of the two arms was poor.
Although there were positive significant outcomes reported for the intervention group,
the precise nutritional content of the intervention/control diet that was consumed by
the participants was not reported, so potential mechanisms could not be explored. Both
diets provided approximately 1200 kcal/day, with participants given a variety of different
food choices per meal, with set portion sizes. Caloric restriction, whereby the calorie
intake is well below what would be consumed ad libitum (>10%), has been shown to
have a positive effect on CV health [81]. The effects of caloric restriction in humans
include beneficial changes in blood pressure, lipid profile, CV function and inflammatory
response [82–84]. It seems possible that a contributing factor towards the positive changes
in the Chinese diet intervention arm was the result of the caloric restriction. Moreover, since
the comparator arm was also energy restricted, the reported results might be attributed to
the specific nutrients in the prescribed diets. However, without knowing which nutrients
were consumed by the participants, it is difficult to draw conclusions.
Three studies investigating the Nordic diet were included in this review. The new
Nordic diet was shown to have positive effects on anthropometric indices and the lipid
profile among obese participants and individuals with elevated TC, respectively [30,32].
The key features of the new Nordic diet, as reported by the authors, include replacing
the SFA content of the diet with MUFA and PUFA sources, reducing the consumption of
processed and refined grains, and increasing the intake of organically grown fruits and
vegetables. In Ulven’s study, the SFA content was 19.2 g/day in the control arm and as low
as 5.7 g/day in the intervention group [32]. The respective PUFA content reached 5.1 g/day
and 14.4 g/day in the control diet and intervention diet, respectively. With regard to the
fat content, as previously mentioned, recent research of a higher hierarchy disputes the
efficacy of SFA replacement in improving CV risk [74]. Thus, the induced changes in the
new Nordic diet arms rely on other factors. Thus, more research is required to explore the
efficacy of the new Nordic diet and its applicability to populations with different CVD
risk factors.
In the present review, there were more studies included that investigated the MedD
that any other regional diet. In all but one of the included studies, the MedD was shown to
have significant positive effects on most outcomes of interest. Key features of the MedD
typically include multiple daily servings of olive oil, tree nuts, fruits and vegetables and
fresh fish, white meat and whole grains, while processed foods, grains, and red meat are
advised to be consumed less than once daily (Figure 3) [54,85,86]. A plethora of meta-
analyses have shown that adherence to the MedD reduces CV risk factors including hard
endpoints [85,86]. Moreover, research also suggests that the MedD can be an effective
remedy for precursors of CVD, including hypertension or obesity [87–89]. Nevertheless,
great heterogeneity is observed with respect to the trials implementing MedD interventions,
their design, fragility index, and intervention characteristics, as well as regarding what is
considered as a MedD by definition [54].
The only study included that investigated the Mexican diet showed positive changes
to Ins and reported no significant positive results for any other biochemical indices of
CVD risk [35]. The nutritional information of the planned interventions showed that the
Mexican diet and the US diet comparator contained approximately the same amount of
calories, with participants prescribed a eucaloric diet depending on their own expenditure.
The Mexican diet contained 32.3 g less sugar daily (18.6 g less fructose), which may explain
why insulin concentrations were significantly reduced in the intervention arm.
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Of the two included studies that investigated the TPM, one showed some significant
positive improvements in the anthropometric and biochemical indices [33], and one showed
none [34]. The nutritional intervention of Razmgah’s study [33] was poorly reported, and
potential causal mechanisms cannot be explored. Hamidnia’s study [34] failed to reveal any
significant positive changes between treatment arms. Thus, based on the available evidence,
the effect of the TPM on CVD risk factors in patients at increased risk appears poor.
With regard to the Southern European Atlantic diet, the overall studies backing the
“healthy diet” narrative are limited, and more research is required to identify the specific
characteristics of this pattern and to associate its adherence with health outcomes.
4.3. Health Benefits of Regional Diets beyond CVD Risk
Apart from CVD, which was the main aim of the present systematic review, high
quality research has revealed that regional dietary patterns may also be effective in other
NCD categories. For instance, meta-analyses of RCTs reveal that the MedD can be an
effective complementary therapy in patients with cancers [90], mental health problems [91],
or diabetes [86,92,93] diagnoses. Similarly, the aggregation of RCTs implementing the new
Nordic diet [94] also revealed improvements in the metabolic control of patients at risk
for diabetes. With regard to the adoption of the traditional Chinese diet and medicine,
meta-analyses of RCTs have showed selective improvements in patients with a cancer [95]
or obesity diagnoses [96]. On the other hand, results from observational studies suggest
that adherence to the traditional Japanese diet reduces the risk for developing specific
cancers, and in parallel lower all-cause, CVD and cancer mortality [97,98].
4.4. Environmental Benefits of Regional Diets
In 1986, Gussow and Clancy [99] were the first to suggest the term “sustainable diet”
to describe a diet composed of foods contributing to health and nutrient adequacy, while
also contributing to the sustainability of food sources (agricultural system, or fishing). Thus,
sustainable diets make use of human and natural resources to produce and consume foods
“in a manner that is not wasteful of finite resources as topsoil, water, and fossil energy” [99].
Therefore, it appears that sustainability is multidimensional, with environmental, economic
and social impacts, aiming to achieve multiple sustainable development goals (SDGs) in
synergy. In this manner, changes in food availability, the industrialization of food systems,
technological advances, globalization of the market and food policies and lobbies have
all induced a nutrition transition deviating from the traditional regional diets. A return
to the traditional regional patterns would not only improve population health, but also
contribute to the sustainability of the environment, while taking into account the identity
and diversity of food systems and cultures of each region [100].
4.5. Limitations of the Present Study
Limitations of the present systematic review include the relatively narrow spectrum
traditional regional diets included in the analysis. It appears that several dietary patterns
have not been examined yet, with respect to their effect on CVD risk. In the present search,
no RCTs were found implementing other traditionally healthy diets with regard to CVD
outcomes, including the Inuit (arctic) diet or the South Asian diet. Moreover, the present
review also highlighted the great heterogeneity in the regional diets RCTs, not allowing for
a synthesis of the evidence.
It should also be noted that an additional limitation of the studies included in the
present systematic review involves the lack of biomarker use for assessing treatment
adherence. A variety of biomarkers are available today and can confer greater validity
when assessing dietary treatment adherence, as compared to the usual tools for dietary
assessment. Some are food specific, evaluating fish, meat, or olive oil intake (including
urine hydroxytysosol or serum γ-tocopherol concentrations) [101–106], whereas others are
nutrient-specific. The use of such biomarkers might have resulted in different findings
with regard to CVD endpoints.
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Moreover, metabolic health often stems from the perfect balance of nutrients, with BP
for example being affected by many micronutrients apart from sodium intake, including
potassium, magnesium, calcium, fish taurine, or soy phytoestrogens. These interacting
micronutrients were not assessed in the included studies and this might have reduced the
efficacy of regional diets on participants’ BP health.
On a side note, in all of the research included herein, specific aspects of the traditional
lifestyle beyond regional diets, including the siesta, reduced stress, improved quality of
life, and social capital, cannot be transferred to an RCT design, although they might induce
improved benefits [54].
Moreover, future research can also aggregate data from the RCTs implementing
regional diets for the prevention of other NCD categories, in order to help us attain a better
picture on the effects of traditional diets on NCD prevention.
5. Conclusions
Regional diets are sustainable dietary patterns that make use of locally sourced goods
to nurture the surrounding populations. With regard to their CVD benefits, we cannot draw
conclusions on whether one specific pattern is superior to another, although the majority
of research involves the MedD. Selective CV outcomes (anthropometry, BP, inflammation
markers) are improved following regional dietary interventions, although aggregation of
data for the recommendation of specific territorial diets for the reduction of CVD risk is
not yet feasible, with the possible exception of the MedD.
Although strengths and areas that benefit differ between the distinct target populations
of the included RCTs, the reviewed body of evidence suggests that adherence to regional
diets may reduce specific CV risk factors, with MedD appearing to offer a wider range of
CV-related benefits. Nevertheless, the evidence is still limited for most of the examined
regional diets and a great heterogeneity is observed. Thus, more research examining the
effects of regional dietary interventions on CVD parameters is required to increase the
body of existing evidence.
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